Bridgeway Capital Management »

Aerovate Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $63k 25k 2.51
2024-12-31 $159k 60k 2.65